You are here:Home-Chemical Inhibitors & Agonists-JAK/STAT Signaling-JAK-LY2784544
LY2784544

Chemical Structure : LY2784544

CAS No.: 1229236-86-5

LY2784544 (LY 2784544;LY-2784544;Gandotinib)

Catalog No.: PC-43343Not For Human Use, Lab Use Only.

LY2784544 (Gandotinib) is a potent, selective and ATP-competitive inhibitor of JAK2V617F, effectively inhibits JAK2V617F-driven signaling and cell proliferation in Ba/F3 cells (IC50=20 and 55 nM, respectively).

Packing Price Stock Quantity
25 mg $175 In stock
50 mg $315 In stock
100 mg $565 In stock
500 mg Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

Biological Activity

LY2784544 (Gandotinib) is a potent, selective and ATP-competitive inhibitor of JAK2V617F, effectively inhibits JAK2V617F-driven signaling and cell proliferation in Ba/F3 cells (IC50=20 and 55 nM, respectively); inhibits JAK2 and JAK3 in biochemical assays with IC50 of 3 nM and 48 nM, respectively; LY2784544 is much less potent at inhibiting IL-3-stimulated wild-type JAK2-mediated signaling and cell proliferation (IC50=1183 and 1309 nM, respectively); effectively inhibits STAT5 phosphorylation in Ba/F3-JAK2V617F-GFP ascitic tumor cells (TED50=12.7 mg/kg) and significantly reduces Ba/F3-JAK2V617F-GFP tumor burden in the JAK2V617F-induced MPN model; also is a potent GPR39 agonist with pEC50 of 9.36 (at 316 uM ZnCl2).

Blood Cancer

Phase 2 Clinical

Physicochemical Properties

M.Wt 469.9423
Formula C23H25ClFN7O
Appearance Solid
CAS No.
Storage
Solide Powder
-20 °C 12 Months; 4°C 6 Months
In Solvent
-80 °C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

Imidazo[1,2-b]pyridazin-6-amine, 3-[(4-chloro-2-fluorophenyl)methyl]-2-methyl-N-(5-methyl-1H-pyrazol-3-yl)-8-(4-morpholinylmethyl)-

References

1. Ma L, et al. Blood Cancer J. 2013 Apr 12;3:e109.

2. Telford BJ, et al. Mol Cancer Ther. 2015 May;14(5):1213-23.

3. Gunerka P, et al. Eur J Pharmacol. 2015 Oct 15;765:188-97.

4. Sato S, et al. Mol Pharmacol. 2016 Dec;90(6):726-737.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: